BIO Deutschland at the Finance Day Leipzig

Foto: v. l. Viola Bronsema, Anne-Kristin Heninger (Seamless Therapeutics) und Jens Ruhe (SciRhom) © OXYGEN Pictures GmbH

For 18 years, the Finance Day hosted by BIO Deutschland e. V. member Going Public has been dedicated to start-up, growth and capital market financing in the life sciences industry. This year, the event took place in Leipzig for the first time on 24 and 25 October. Andre Hofmann, managing director and CEO of Biosaxony, and Markus Rieger, CEO of Going Public, welcomed the approximately 150 participants to Biocity Leipzig. Presentations, discussion panels and start-up pitches offered insights into the scene. Karin Hofelich, Head of Life Sciences Publishing, invited BIO Deutschland to lead the panel discussion “How to...? Successful locals and beacons from across Germany reveal their secrets of success”. Dr. Anne-Kristin Heninger, Head of Operations, founder and Managing Director of Seamless Therapeutics, Ben Orzelek, Senior Director, Head of Treasury & Investor Relations of ITM Isotope Technologies Munich SE, Jens Ruhe, COO and founder of SciRhom and Marc Struhalla, CEO and founder of c-LEcta GmbH talked about the beginnings of their companies, their financing rounds, their business models and the paths to the future. An entertaining evening event and a tour of the Biocity on the following day rounded off the program. Founded in 1998, GoingPublic Media AG is one of the leading media companies for corporate finance and investment topics. The group operates three cross-media platforms, focusing on the capital market (capital market platform GoingPublic), family businesses/medium-sized companies (platform Unternehmeredition, trade magazine FuS) and life sciences (platform Life Sciences). GoingPublic Media AG (WKN 761210) is listed in the Quotation Board of the Frankfurt Stock Exchange (trading on Xetra) and in M:access, the SME segment of the Munich Stock Exchange.